Dr. Jeffrey L. Berenberg
Claim this profileStraub Clinic and Hospital
Expert in Lung Cancer
Expert in Cancer
28 reported clinical trials
75 drugs studied
About Jeffrey L. Berenberg
Education:
- Obtained MD from the University of Miami School of Medicine in 1985.
- Completed Residency in Internal Medicine at Jackson Memorial Hospital (1985-1988).
- Undertook Fellowship in Gastroenterology at the University of Miami School of Medicine (1988-1991).
Experience:
- Practices as a gastroenterologist at Straub Clinic and Hospital.
Area of expertise
1Lung Cancer
Global LeaderStage III
Stage II
Stage IV
2Cancer
Global LeaderStage III
Stage II
Stage I
Affiliated Hospitals
Clinical Trials Jeffrey L. Berenberg is currently running
Genetic Testing
for Early-Stage Lung Cancer
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
More about Jeffrey L. Berenberg
Clinical Trial Related7 years of experience running clinical trials · Led 28 trials as a Principal Investigator · 13 Active Clinical TrialsTreatments Jeffrey L. Berenberg has experience with
- Nivolumab
- Ipilimumab
- Pembrolizumab
- Carboplatin
- Gemcitabine Hydrochloride
- Magnetic Resonance Imaging
Breakdown of trials Jeffrey L. Berenberg has run
Lung Cancer
Cancer
Non-Small Cell Lung Cancer
Breast Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jeffrey L. Berenberg specialize in?
Jeffrey L. Berenberg focuses on Lung Cancer and Cancer. In particular, much of their work with Lung Cancer has involved Stage III patients, or patients who are Stage II.
Is Jeffrey L. Berenberg currently recruiting for clinical trials?
Yes, Jeffrey L. Berenberg is currently recruiting for 12 clinical trials in Honolulu Hawaii. If you're interested in participating, you should apply.
Are there any treatments that Jeffrey L. Berenberg has studied deeply?
Yes, Jeffrey L. Berenberg has studied treatments such as Nivolumab, Ipilimumab, Pembrolizumab.
What is the best way to schedule an appointment with Jeffrey L. Berenberg?
Apply for one of the trials that Jeffrey L. Berenberg is conducting.
What is the office address of Jeffrey L. Berenberg?
The office of Jeffrey L. Berenberg is located at: Straub Clinic and Hospital, Honolulu, Hawaii 96813 United States. This is the address for their practice at the Straub Clinic and Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.